Related references
Note: Only part of the references are listed.Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: the Importance of Heteroresistance for Growth Outcome
Iain J. Abbott et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in US Hospitals, 2013 to 2018
Marya D. Zilberberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Contribution of hypermutation to fosfomycin heteroresistance in Escherichia coli
Ines Portillo-Calderon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant
Selay Demirci-Duarte et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
Jurgen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification
Herve Nicoloff et al.
NATURE MICROBIOLOGY (2019)
Mechanisms and clinical relevance of bacterial heteroresistance
Dan Andersson et al.
NATURE REVIEWS MICROBIOLOGY (2019)
An in vitro experimental study of the effect of fosfomycin in combination with amikacin, ciprofloxacin or meropenem on biofilm formation by multidrug-resistant urinary isolates of Escherichia coli
Sugalya Sugathan et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2019)
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Alessandro Cassini et al.
LANCET INFECTIOUS DISEASES (2019)
Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli
Aaron E. Lucas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae
John K. Diep et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy
Fekade Bruck Sime et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing Klebsiella pneumoniae
Wei Yu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniae
Miao Zhao et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Molecular insights into fosfomycin resistance in Escherichia coli
M. Ballestero-Tellez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and blaNDM-5: Preparation for a Postantibiotic Era
Zackery P. Bulman et al.
MBIO (2017)
In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae
Wei Yu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model
Brian VanScoy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review
Abi Jenkins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
F. Docobo-Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience
Marco Cavaleri et al.
CLINICAL INFECTIOUS DISEASES (2015)
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model
Bhagwan Yadav et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-beta-lactamase-producing Klebsiella oxytoca
Salvador Vergara-Lopez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Fosfomycin Susceptibility in Carbapenem-Resistant Enterobacteriaceae from Germany
Martin Kaase et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Quantification of amikacin and kanamycin in serum using a simple and validated LC-MS/MS method
Jacob A. Dijkstra et al.
BIOANALYSIS (2014)
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
Alfredo Castaneda-Garcia et al.
ANTIBIOTICS-BASEL (2013)
Prevalence of acquired fosfomycin resistance among extended-spectrum -lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3
So-Young Lee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Structural Basis of Substrate Selectivity in the Glycerol-3-Phosphate: Phosphate Antiporter GlpT
Christopher J. Law et al.
BIOPHYSICAL JOURNAL (2009)
Rapid and selective liquid chromatographic/tandem mass spectrometric method for the determination of fosfomycin in human plasma
Li Li et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Polymorphic mutation frequencies in Escherichia coli:: Emergence of weak mutators in clinical isolates
MR Baquero et al.
JOURNAL OF BACTERIOLOGY (2004)
Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis
B Pfausler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Share Paper
